# The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer

> **NCT06208436** · — · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Pancreas Cancer
- Chemotherapy

## Interventions

- **OTHER:** Adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT06208436
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-07
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-02-28
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06208436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06208436, "The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06208436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*